Role of endoplasmic reticulum, endosomal-lysosomal compartments, and microtubules in amyloid precursor protein metabolism of human neurons

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 1832-1842

  LeBlanc, Andréa C ^a,b   Goodyer, Cynthia G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Amyloid peptide; Amyloid precursor protein metabolism; Endosomal lysosomal pathway; Human primary neuron cultures; Secretory pathway

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL TYPE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOSOME; HUMAN; HUMAN CELL; LYSOSOME; MICROTUBULE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM;

AMMONIUM CHLORIDE; AMYLOID; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; CELLS, CULTURED; CHLOROQUINE; CYSTEINE ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; ENDOSOMES; GOLGI APPARATUS; HUMANS; LYSOSOMES; MICROTUBULES; NEURONS; PEPTIDE HYDROLASES; POLYMERS; REFERENCE VALUES; SERINE ENDOPEPTIDASES;

RODENTIA;

EID: 0033010058     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721832.x     Document Type: Article

References (73)

1. Benowitz L., Rodriguez W., Paskevich P., Mufson E., Schenk D., and Neve R. (1989) The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp. Neurol. 106, 237-250.
2. Bloom G. S. and Goldstein L. S. B. (1998) Cruising along microtubule highways: how membranes move through the secretory pathway. J. Cell Biol. 140, 1277-1280.
3. Bonifacino J. and Lippincott-Schwartz J. (1991) Degradation of proteins within the endoplasmic reticulum. Curr. Opin. Biol. 3, 592-600.
4. Bosman G., Engbersen A., Vollaard C., Bartholomeus I., Pistorius A., Renkawek K., and Degrip W. (1996) Implications of aging- and degeneration-related changes in anion exchange proteins for the maintenance of neuronal homeostasis. Cell. Mol. Biol. 42, 905-918.
5. Busciglio J., Gabuzda D., Matsudaira P., and Yankner B. (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 2092-2096.
6. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
7. Buxbaum J., Ruefli A., Parker C., Cypress A., and Greengard P. (1993) Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad Sci. USA 91, 4489-4493.
8. Caporaso G. L., Gandy S. E., Buxbaum J. D., and Greengard P. (1992) Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 2252-2256.
9. Cardelli J., Richardson J., and Miears D. (1989) Role of acidic intracellular compartments in the biosynthesis of Dictyostelium lysosomal enzymes. The weak bases ammonium chloride and chloroquine differentially affect proteolytic processing and sorting. J. Biol. Chem. 264, 3454-3463.
10. Cheung T., Ghiso J., Shoji M., Cai X., Golde T., Gandy S., Frangione B., and Younkin S. (1994) Characterization by radiosequencing of the carboxyl-terminal derivatives produced from normal and mutant amyloid β protein precursors. Amyloid; Int. J. Exp. Clin. Invest. 1, 30-38.
11. Chyung A., Greenberg B., Cook D., Doms R., and Lee V. (1997) Novel β-secretase cleavage of β-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J. Cell Biol. 138, 671-680.
12. Citron M., Diehl T. S., Capell A., Haass C., Teplow D. B., and Selkoe D. J. (1996) Inhibition of amyloid-β-protein production in neural cells by the serine inhibitor AEBSF. Neuron 17, 171-179.
13. Cole N. B., Sciaky N., Marotta A., Song J., and Lippincott-Schwartz J. (1996) Golgi dispersal during microtubule disruption: regeneration of Golgi stacks at peripheral endoplasmic reticulum exit sites. Mol. Biol. Cell 7, 631-650.
14. Comings Saido T., Yokota M., Maruyama K., Yamao-Harigaya W., Tani E., Ihara Y., and Kawashima S. (1994) Spatial resolution of the primary β-amyloidogenic process induced in postischemic hippocampus. J. Biol. Chem. 269, 15253-15257.
15. Cook D., Forman M., Sung J., Leight S., Kolson D., Iwatsubo T., Lee V., and Doms R. (1997) Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3, 1021-1023.
16. Del Canto M. (1996) The Golgi apparatus and the pathogenesis of Alzheimer's disease. Am. J. Pathol. 148, 355-360.
17. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., and Dotti C. G. (1995) Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14, 4932-4938.
18. Efthimiopoulos S., Vassilacopoulos D., Ripellino J. A., Tezapsidis N., and Robakis N. K. (1996) Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. Proc. Natl. Acad. Sci. USA 93, 8046-8050.
19. Esch F., Keim P., Beatties E., Blacher R., Culwell A., Oltersdorf T., McClure D., and Ward P. (1990) Cleavage of the amyloid β peptide during constitutive processing of its precursor. Science 248, 1122-1124.
20. Estus S., Golde T., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B., and Younkin S. (1992) Potentially amyloidogenic, carboxy-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
21. Gabuzda D., Busciglio J., and Yankner B. A. (1993) Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61, 2326-2329.
22. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid protein. Nature 373, 523-527.
23. Golde T., Estus S., Younkin L., Selkoe D., and Younkin S. (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730.
24. Haass C., Hung A., Schlossmacher M., Teplow D., and Selkoe D. (1993) β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
25. Haass C., Koo E., Mellon A., Hung A., and Selkoe D. (1992a) Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
26. Haass C., Schlossmacher M., Hung A., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E., Schenk D., Teplow D., and Selkoe D. (1992b) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
27. Haass C., Koo E. H., Capell A., Teplow D., and Selkoe D. (1995) Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J. Cell Biol. 128, 537-547.
28. Hartmann T., Bieger S., Bruhl B., Tienari P., Ida N., Allsop D., Roberts G., Masters C., Dotti C., Unsicker K., and Beyreuther K. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat. Med. 3, 1016-1020.
29. Higaki J., Quon D., Zhong Z., and Cordell B. (1995) Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14, 651-659.
30. Higgins L. S., Rodems J. M., Catalano R., and Cordell B. (1995) Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc. Natl. Acad. Sci. USA 92, 4402-4406.
31. Hsiao K., Borcheldt D., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Clark B., and Carlson G. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor protein. Neuron 15, 1203-1208.
32. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaque formation in transgenic mice. Science 274, 99-102.
33. Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H., and Selkoe D. J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268, 22959-22962.
34. Iwatsubo T., Okada A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53.
35. Jacobsen J. S., Spruyt M. A., Brown A. M., Sahasrabhude S., Blume A., Vitek M., Muenkell H., and Sonnenberg-Reines J. (1994) The release of Alzheimer's disease β-amyloid peptide is reduced by phorbol treatment. J. Biol. Chem. 269, 8376-8382.
36. Kim K., Miller D., Sapienza V., Chen C., Bai C., Grundke-Iqbal I., Currie J., and Wisniewski H. (1990a) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
37. Kim K. S., Wen G. Y., Bancher C., Chen C. M. J., Sapienza V. J., Hong H., and Wisniewski H. M. (1990b) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122.
38. Klausner R., Donaldson J., and Lippincott-Schwartz J. (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116, 1071-1080.
39. Knops J., Suomensaari S., Lee M., McConlogue L., Seubert P., and Sinha S. (1995) Cell-type and amyloid precursor protein-type specific inhibition of Aβ release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J. Biol. Chem. 270, 2419-2422.
40. Koo E. H. and Squazzo S. L. (1994) Evidence that production of amyloid β-protein involves the endocytotic pathway. J. Biol. Chem. 269, 17386-17389.
41. LeBlanc A. C. (1995) Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci. 15, 7837-7846.
42. LeBlanc A., Kovacs D., Chen H., Villare F., Tykocinski M., Autilio-Gambetti L., and Gambetti P. (1992) Role of amyloid precursor protein (APP): study with antisense transfection of human. J. Neurosci. Res. 31, 635-645.
43. LeBlanc A. C., Xue R., and Gambetti P. (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 2300-2310.
44. LeBlanc A. C., Papadopoulos M., Bélair C., Chu W., Crosato M., Powell J., and Goodyer C. G. (1997) Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J. Neurochem. 68, 1183-1190.
45. LeBlanc A. C., Koutroumanis M., and Goodyer C. (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuron cultures. J. Neurosci. 18, 2907-2913.
46. Mains R. and May V. (1988) The role of a low pH intracellular compartment in the processing, storage, and secretion of ACTH and endorphins. J. Biol. Chem. 263, 7887-7894.
47. Maxfield F. (1982) Weak bases and ionophores rapidly and reversibly raise the pH of endocytotic vesicles in cultured mouse fibroblasts. J. Cell Biol. 95, 676-681.
48. Milward E., Papadopoulos R., Fuller S., Moir R., Small D., Beyreuther K., and Masters C. (1992) The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
49. Munger J. S., Haass C., Lemere C., Shi G.-P., Wong F., Teplow D. B., Selkoe D. J., and Chapman H. A. (1995) Lysosomal pressing of amyloid precursor protein to peptides: a distinct role for cathepsin S. Biochem. J. 311, 299-305.
50. Naidu A., Quon D., and Cordell B. (1995) β-Amyloid peptide produced in vitro is degraded by proteinase released by cultured cells. J. Biol. Chem. 270, 1369-1374.
51. Nitsch R., Slack B., Wurtman R., and Growdon J. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
52. Perez R. G., Squazzo S. L., and Koo E. H. (1996) Enhanced release of amyloid-β-protein from codon 670-671 "Swedish" mutant β-amyloid precursor protein occurs in both secretory and endocytic pathway. J. Biol. Chem. 271, 9100-9107.
53. Perez R. G., Zheng H., Van der Ploeg L., and Koo E. H. (1997) The β-amyloid protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17, 9407-9414.
54. Qiu W., Borth W., Ye Z., Haass C., Teplow D., and Selkoe D. (1996) Degradation of amyloid β protein by a serine protease-α2-macroglobulin complex. J. Biol. Chem. 271, 8443-8451.
55. Querfurth H. W. and Selkoe D. J. (1994) Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33, 4550-4561.
56. Quon D., Wang Y., Catalano R., Scardina J., Murakami K., and Cordell B. (1991) Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241.
57. Ripellino J. A., Vassilacopoulos D., and Robakis N. K. (1994) Solubilization of full length amyloid precursor proteins from PC12 cell membranes. J. Neurosci. Res. 39, 211-218.
58. Savage M., Trusko S., Howland D., Pinsker L., Misretta S., Reaume A., Greenberg B., Siman R., and Scott R. (1998) Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18, 1743-1752.
59. Schagger H. and Von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 KDa. Anal. Biochem. 166, 368-379.
60. Schubert D., Jin L.-W., Saitoh T., and Cole G. (1989) The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion. Neuron 3, 689-694.
61. Selkoe D. (1997) Alzheimer's disease: genotypes, phenotype and treatments. Science 275, 630-631.
62. Seubert P., Oltersdorf T., Lee M., Barbour R., Blomquist C., Davis D., Bryant K., Fritz L. C., Galasko D., Thal L. J., Lieberburg I., and Schenk D. (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260-263.
63. Sheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
64. Shoji M., Golde T., Ghiso J., Cheung T., Estus S., Shaffer L., Cai X., McKay D., Tintner R., Frangione B., and Younkin S. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
65. Stafford F. J. and Bonifacino J. S. (1991) A permeabilized cell system identifies the endoplasmic reticulum as a site of protein degradation. J. Cell Biol. 115, 1225-1236.
66. Stoller T. and Shields D. (1989) The role of paired basic amino acids in mediating proteolytic cleavage of prosomatostatin. Analysis using site directed mutagenesis. J. Biol. Chem. 264, 6922-6928.
67. Tienari P., Ida N., Ikonen E., Simons M., Weidemann A., Multhaup G., Masters C., Dotti C., and Beyreuther K. (1997) Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 94, 4125-4130.
68. Wang R., Sweeney D., Gandy S., and Sisodia S. (1996) The profile of soluble amyloid β protein in cultured cell media. J. Biol. Chem. 271, 31894-31902.
69. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C. L., and Beyreuther K. (1997) Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nat. Med. 3, 328-332.
70. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., and Haass C. (1997) Intracellular generation and accumulation of amyloid β peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085-16088.
71. Wolf B., Wertkin A., Jolly Y., Yasuda R., Wolfe B., Konrad R., Manning D., Ravi S., Williamson J., and Lee V. (1995) Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein in human neuronal NT2N cells. J. Biol. Chem. 270, 4916-4922.
72. Yamazaki T., Selkoe D. J., and Koo E. H. (1995) Trafficking of cell surface β-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129, 431-442.
73. Zheng H., Jiang M., Trumbauer M., Sirinathsinghji D., Hopkins R., Smith D., Heavens R., Dawson G., Boyce S., Conner M., Stevens K., Slum H., Sisodia S., Chen H., and Van der Ploeg L. (1995) β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.